Cidara Therapeutics, Inc.

New Filing
CIK: 0001610618·Biotechnology·DELAWARE·Filed: May 30, 2018
Total Offering

$1,874,999

Amount Sold

$1,562,499

Investors

16

First Sale

May 23, 2018

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Jeffrey Stein
Related Person
Daniel D. Burgess
Related Person
Scott M Rocklage
Related Person
Theodore R. Schroeder
Related Person
Robert J Perez
Related Person
Timothy R Franson
Related Person
Matthew Onaitis
Related Person
Taylor Sandison
Related Person
Chrysa Mineo
Related Person

Company

Cidara Therapeutics, Inc.

6310 NANCY RIDGE DRIVE

SAN DIEGO, CA, 92121

858-752-6170

SEC Filing

0001736945-18-000006

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free